An Outbreak of Severe Group A Streptococcus Infections Associated with Podiatric Application of a Biologic Dermal Substitute
- PMID: 26673775
- DOI: 10.1017/ice.2015.306
An Outbreak of Severe Group A Streptococcus Infections Associated with Podiatric Application of a Biologic Dermal Substitute
Abstract
Objective: To describe an outbreak of severe Group A Streptococcus (GAS) infections that appeared to be associated with use of a biologic dermal substitute on foot wounds
Design: Retrospective cohort study of cases and similar uninfected patients
Setting/patients: Patients attending the podiatry clinic at a Veterans Affairs Medical Center between July 2011 and November 2011 INTERVENTIONS: Microbiology laboratory data were reviewed for the calendar year, a case definition was established and use of the biologic dermal substitute was discontinued. Staff were cultured to identify potentially colonized employees. A case-cohort study was designed to investigate risk factors for disease. Emm typing and pulsed field gel electrophoresis (PFGE) were performed to identify strain similarity.
Results: In 10 months, 14 cases were identified, and 4 of these patients died. All strains were emm type 28 and were identical according to PFGE. Discontinuation of biologic dermal substitute use halted the outbreak. A prior stroke was more common in the case cohort vs uninfected patient cohorts. The number of patients attending the clinic on 13 probable transmission days was significantly higher than on nontransmission days. We identified 2 patients who were present in the clinic on all but 1 probable transmission day. Surveillance cultures of podiatry clinic staff and cultures of the same lot of retained graft material were negative.
Conclusions: A carrier was not identified, and we believe the outbreak was associated with inter-patient transmission likely due to lapses in infection control techniques. No additional cases have been identified in >3 years following the resumption of dermal substitute use in May 2012.
Similar articles
-
Invasive Group A Streptococcus Outbreaks Associated with Home Healthcare, England, 2018-2019.Emerg Infect Dis. 2022 May;28(5):915-23. doi: 10.3201/eid2805.211497. Emerg Infect Dis. 2022. PMID: 35451366 Free PMC article. Review.
-
Outbreak of invasive group A streptococcal disease among children attending a day-care center.Pediatr Infect Dis J. 2008 Jul;27(7):602-4. doi: 10.1097/INF.0b013e31816a0e0a. Pediatr Infect Dis J. 2008. PMID: 18520444
-
Nursing home outbreak of invasive group a streptococcal infections caused by 2 distinct strains.Infect Control Hosp Epidemiol. 2007 Jan;28(1):68-74. doi: 10.1086/508821. Epub 2006 Dec 15. Infect Control Hosp Epidemiol. 2007. PMID: 17230390
-
Outbreak of invasive group A streptococcus infection: contaminated patient curtains and cross-infection on an ear, nose and throat ward.J Hosp Infect. 2014 Jul;87(3):141-4. doi: 10.1016/j.jhin.2014.04.007. Epub 2014 May 10. J Hosp Infect. 2014. PMID: 24928787
-
Group A Streptococcus Toxic Shock Syndrome: An outbreak report and review of the literature.J Infect Public Health. 2012 Dec;5(6):388-93. doi: 10.1016/j.jiph.2012.07.006. Epub 2012 Nov 30. J Infect Public Health. 2012. PMID: 23287609 Review.
Cited by
-
Invasive Group A Streptococcus Outbreaks Associated with Home Healthcare, England, 2018-2019.Emerg Infect Dis. 2022 May;28(5):915-23. doi: 10.3201/eid2805.211497. Emerg Infect Dis. 2022. PMID: 35451366 Free PMC article. Review.
-
Interpretation and clinical practice of regulation for prevention and control of healthcare associated infection in outpatient and emergency department in healthcare facilities.Ann Transl Med. 2019 Jan;7(1):10. doi: 10.21037/atm.2018.12.05. Ann Transl Med. 2019. PMID: 30788357 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical